Dr. Parikh on Determining Transplant Eligibility in HCC

Video

Neehar Parikh, MD, discusses criteria for determining transplant eligibility in hepatocellular carcinoma.

Neehar Parikh, MD, medical director, Multidisciplinary Liver Tumor Clinic, Living Donor Liver Transplantation Program, assistant professor, Michigan Medicine, University of Michigan, discusses criteria for determining transplant eligibility in hepatocellular carcinoma (HCC).

Though transplant eligibility can vary between centers, the Milan Criteria for Liver Transplantation have helped standardize the criteria that are used to assess whether a patient is fit to undergo transplant, explains Parikh.

The criteria for accepting transplant candidates are relatively selective, says Parikh. Other qualifications such as lack of social support and psychosocial issues may render a patient ineligible for transplant.

In some cases, patients who do not meet the standard eligibility criteria are transplanted through living donors or are treated with alternative therapies as a bridge to transplant, concludes Parikh.

Related Videos
Ricardo D. Parrondo, MD, hematologist/oncologist, Mayo Clinic
Ilyas Sahin, MD
Raj Singh, MD
Jaime R. Merchán, MD, professor, co-leader, Translational and Clinical Oncology Research Program, director, Phase 1 Clinical Trials Program, Department of Medicine, Division of Medical Oncology, the University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Saad J. Kenderian, MB, CHB
Tycel Phillips, MD
Minesh Mehta, MD
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,